{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T20:32:21Z","timestamp":1770064341958,"version":"3.49.0"},"reference-count":15,"publisher":"American Society of Hematology","issue":"12","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,9,21]]},"abstract":"<jats:title\/>\n               <jats:p>A significant proportion of older patients with immune thrombocytopenia (ITP) also have clinical indications for treatment of cardiovascular disease with antiplatelet agents. Ollier and colleagues sought to determine the frequency of bleeding in patients with ITP on aspirin therapy, finding that the pattern of bleeding, segregated by platelet count, is similar to that observed in other adults with ITP not on aspirin. They show that a platelet count of &amp;lt;20 \u00d7 109\/L is associated with most bleeding in ITP patients on antiplatelet agents.<\/jats:p>","DOI":"10.1182\/blood.2023020311","type":"journal-article","created":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T20:11:05Z","timestamp":1689970265000},"page":"1099-1101","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":6,"title":["Platelet count threshold for hemorrhage in patients with immune thrombocytopenia treated with antiplatelet agents"],"prefix":"10.1182","volume":"142","author":[{"given":"Natasha","family":"Ollier","sequence":"first","affiliation":[{"name":"1Department of Internal Medicine, Toulouse University Hospital, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2619-0952","authenticated-orcid":false,"given":"Marie-L\u00e9a","family":"Piel-Julian","sequence":"additional","affiliation":[{"name":"1Department of Internal Medicine, Toulouse University Hospital, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9182-1434","authenticated-orcid":false,"given":"Matthieu","family":"Mah\u00e9vas","sequence":"additional","affiliation":[{"name":"2Department of Internal Medicine, National Referral Center for Adult's Immune Cytopenias, Henri Mondor University Hospital, Assistance Publique\u2013H\u00f4pitaux de Paris, Paris-Est Cr\u00e9teil University, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7500-9323","authenticated-orcid":false,"given":"Jean-Fran\u00e7ois","family":"Viallard","sequence":"additional","affiliation":[{"name":"3Department of Internal Medicine, Bordeaux University Hospital, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thibault","family":"Comont","sequence":"additional","affiliation":[{"name":"4Department of Internal Medicine, Toulouse University Institute for Cancer, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"Ch\u00e8ze","sequence":"additional","affiliation":[{"name":"5Department of Hematology, Caen University Hospital, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvain","family":"Audia","sequence":"additional","affiliation":[{"name":"6Department of Internal Medicine, Dijon University Hospital, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mika\u00ebl","family":"Ebbo","sequence":"additional","affiliation":[{"name":"7Department of Internal Medicine, Marseille University Hospital, Assistance Publique\u2013H\u00f4pitaux de Marseille, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louis","family":"Terriou","sequence":"additional","affiliation":[{"name":"8Department of Internal Medicine, Lille University Hospital, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9398-2968","authenticated-orcid":false,"given":"Jean-Christophe","family":"Lega","sequence":"additional","affiliation":[{"name":"9Department of Internal Medicine, Lyon University Hospital, H\u00f4pitaux Civils de Lyon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre-Yves","family":"Jeandel","sequence":"additional","affiliation":[{"name":"10Department of Internal Medicine, Nice University Hospital, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Bonnotte","sequence":"additional","affiliation":[{"name":"6Department of Internal Medicine, Dijon University Hospital, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Michel","sequence":"additional","affiliation":[{"name":"2Department of Internal Medicine, National Referral Center for Adult's Immune Cytopenias, Henri Mondor University Hospital, Assistance Publique\u2013H\u00f4pitaux de Paris, Paris-Est Cr\u00e9teil University, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5494-5873","authenticated-orcid":false,"given":"Maryse","family":"Lapeyre-Mestre","sequence":"additional","affiliation":[{"name":"11Clinical Investigation Center 1436, Team PEPSS (PharmacoEpidemiology, Populations, cohortS, biomarkerS), Toulouse University Hospital, France"},{"name":"12Department of Clinical Pharmacology, Toulouse University Hospital, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bertrand","family":"Godeau","sequence":"additional","affiliation":[{"name":"2Department of Internal Medicine, National Referral Center for Adult's Immune Cytopenias, Henri Mondor University Hospital, Assistance Publique\u2013H\u00f4pitaux de Paris, Paris-Est Cr\u00e9teil University, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9953-4640","authenticated-orcid":false,"given":"Guillaume","family":"Moulis","sequence":"additional","affiliation":[{"name":"1Department of Internal Medicine, Toulouse University Hospital, France"},{"name":"11Clinical Investigation Center 1436, Team PEPSS (PharmacoEpidemiology, Populations, cohortS, biomarkerS), Toulouse University Hospital, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"issue":"2","key":"2023092115242779700_bib1","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2141.2009.07615.x","article-title":"Epidemiology of immune thrombocytopenic purpura in the General Practice Research Database","volume":"145","author":"Schoonen","year":"2009","journal-title":"Br J Haematol"},{"issue":"22","key":"2023092115242779700_bib2","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1182\/blood-2014-05-578336","article-title":"Epidemiology of incident immune thrombocytopenia: a nationwide population-based study in France","volume":"124","author":"Moulis","year":"2014","journal-title":"Blood"},{"issue":"5","key":"2023092115242779700_bib3","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/bjh.17390","article-title":"Thrombosis in immune thrombocytopenia - current status and future perspectives","volume":"194","author":"Swan","year":"2021","journal-title":"Br J Haematol"},{"issue":"3","key":"2023092115242779700_bib4","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/bjh.17709","article-title":"Risk factors of hospitalisation for thrombosis in adults with primary immune thrombocytopenia, including disease-specific treatments: a French nationwide cohort study","volume":"195","author":"Lafaurie","year":"2021","journal-title":"Br J Haematol"},{"issue":"22","key":"2023092115242779700_bib5","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1182\/bloodadvances.2019000812","article-title":"Updated international consensus report on the investigation and management of primary immune thrombocytopenia","volume":"3","author":"Provan","year":"2019","journal-title":"Blood Adv"},{"issue":"1","key":"2023092115242779700_bib6","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s11239-018-1649-7","article-title":"Management of antithrombotic therapy in adults with immune thrombocytopenia (ITP): a survey of ITP specialists and general hematologist-oncologists","volume":"46","author":"Pishko","year":"2018","journal-title":"J\u00a0Thromb Thrombolysis"},{"issue":"23","key":"2023092115242779700_bib7","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1182\/bloodadvances.2019000966","article-title":"American Society of Hematology 2019 guidelines for immune thrombocytopenia","volume":"3","author":"Neunert","year":"2019","journal-title":"Blood Adv"},{"issue":"6","key":"2023092115242779700_bib8","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/ajh.24702","article-title":"Newly diagnosed immune thrombocytopenia adults: clinical epidemiology, exposure to treatments, and evolution: results of the CARMEN multicenter prospective cohort","volume":"92","author":"Moulis","year":"2017","journal-title":"Am J Hematol"},{"issue":"11","key":"2023092115242779700_bib9","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1182\/blood-2008-07-162503","article-title":"Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group","volume":"113","author":"Rodeghiero","year":"2009","journal-title":"Blood"},{"issue":"9","key":"2023092115242779700_bib10","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1111\/jth.14227","article-title":"Risk factors for bleeding, including platelet count threshold, in newly diagnosed immune thrombocytopenia adults","volume":"16","author":"Piel-Julian","year":"2018","journal-title":"J\u00a0Thromb Haemostasis"},{"issue":"6","key":"2023092115242779700_bib11","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/jth.14446","article-title":"Cardiovascular and bleeding outcomes in a population-based cohort of patients with chronic immune thrombocytopenia","volume":"17","author":"Adelborg","year":"2019","journal-title":"J\u00a0Thromb Haemostasis"},{"issue":"2","key":"2023092115242779700_bib12","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1093\/ehjcvp\/pvv054","article-title":"Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the Working Group for Cardiovascular Pharmacotherapy of the European Society of Cardiology","volume":"2","author":"Schmidt","year":"2016","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"5","key":"2023092115242779700_bib13","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1182\/blood-2009-08-236679","article-title":"The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy","volume":"115","author":"Dragani","year":"2010","journal-title":"Blood"},{"issue":"5","key":"2023092115242779700_bib14","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/bjh.18111","article-title":"Registries in immune thrombocytopenia (ITP) in Europe: the European Research Consortium on ITP (ERCI) network","volume":"197","author":"Moulis","year":"2022","journal-title":"Br J Haematol"},{"issue":"5","key":"2023092115242779700_bib15","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1111\/bjh.17935","article-title":"Primary immune thrombocytopenia in very elderly patients: particularities in presentation and management: results from the prospective CARMEN-France Registry","volume":"196","author":"Sokal","year":"2022","journal-title":"Br J Haematol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/142\/12\/1099\/2077538\/blood_bld-2023-020311-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/142\/12\/1099\/2077538\/blood_bld-2023-020311-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T15:24:43Z","timestamp":1695309883000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/142\/12\/1099\/497011\/Platelet-count-threshold-for-hemorrhage-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,21]]},"references-count":15,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,9,21]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2023020311","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,21]]}}}